Cite

HARVARD Citation

    Kapniari, E. et al. (2020). Comorbidities burden and previous exposure to biological agents may predict drug survival of apremilast for psoriasis in a real‐world setting. Dermatologic therapy. 33 (6), p. n/a. [Online]. 
  
Back to record